检索结果 - M.S. Raab
- Showing 1 - 12 results of 12
-
1
PB1983: TRIAL-IN-PROGRESS: PHASE II STUDY OF PHE885, A B-CELL MATURATION ANTIGEN-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN ADULTS WITH RELAPSED AND/OR REFRACTORY MULTIP... 由 N. Munshi, A. Spencer, M. S. Raab, A. Masood, M. Martinez-Prieto, J. Chu, S. Iida, S. Lonial, M. A. Dimopoulos
发表在 HemaSphere (2022-06-01)获取全文
文件 -
2
An artificial intelligence-based 3D-segmentation assessment of sarcopenia utilizing whole-body computed tomography in patients with multiple myeloma 由 U. Dapunt, T. Nonnenmacher, S. Zschäbitz, M. Burghardt, M. Hajiyianni, E.K. Mai, M.S. Raab, C. Müller-Tidow, H.U. Kauczor, H. Goldschmidt, T.D. Do
发表在 Brain and Spine (2024-01-01)获取全文
文件 -
3
P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS FROM THE PHASE 2 GMMG-DA... 由 L. Leypoldt, M. Gavriatopoulou, B. Besemer, H. Salwender, M.-S. Raab, A. Nogai, C. Khandanpour, V. Runde, M. Zago, P. Martus, H. Goldschmidt, C. Bokemeyer, M. Dimopoulos, K. Weisel
发表在 HemaSphere (2022-06-01)获取全文
文件 -
4
P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR... 由 A. M. Lesokhin, B. Arnulf, R. Niesvizky, M. Mohty, N. J. Bahlis, M. H. Tomasson, P. Rodrίguez-Otero, H. Quach, N. S. Raje, S. Iida, M.-S. Raab, A. Czibere, S. Sullivan, E. Leip, A. Viqueira, X. Leleu
发表在 HemaSphere (2022-06-01)获取全文
文件 -
5
P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESS... 由 H Einsele, AD Cohen, M Delforge, J Hillengass, H Goldschmidt, K Weisel, M-S Raab, C Scheid, JM Schecter, KC De Braganca, H Varsos, T-M Yeh, L Wang, M Vogel, C Corsale, M Akram, L Pacaud, T Nesheiwat, M Agha, YC Cohen
发表在 HemaSphere (2022-04-01)获取全文
文件 -
6
P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES... 由 J. Hillengass, A. D. Cohen, M. Delforge, H. Einsele, H. Goldschmidt, K. Weisel, M.-S. Raab, C. Scheid, J. M. Schecter, K. C. De Braganca, H. Varsos, T.-M. Yeh, P. Mistry, T. Roccia, C. Corsale, M. Akram, L. Pacaud, T. Nesheiwat, M. Agha, Y. C. Cohen
发表在 HemaSphere (2022-06-01)获取全文
文件 -
7
P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA 由 M. S. Raab, Y. C. Cohen, F. Schjesvold, K. Aardalen, A. Oka, A. Spencer, M. Wermke, P. Hari, J. L. Kaufman, A. M. Cafro, E. M. Ocio, N. Doki, K. Henson, G. Trabucco, P.-E. Juif, R. Chawla, J. Cotton, A. Fessehatsion, L. Fan, J. Blankenship, B. Granda, H. Lu, S. De Vita
发表在 HemaSphere (2022-06-01)获取全文
文件 -
8
C004 | REALITEC: A MULTI-COUNTRY OBSERVATIONAL RETROSPECTIVE STUDY OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OUTSIDE OF CLINICAL TRIALS 由 C. Liberatore, M.C. Da Vià, K.M. Kortüm, K. Uttervall, R. Popat, S.L. Farmer, B. Kishore, C. Jacquet, M. Casanova, M. Hansson, K. Weisel, H. Magen, C. Toftmann Hansen, M.E. Gatt, T. Shragai, T. De Soto Alvarez, M. Streetly, M-S. Raab, S. Manier, J. Aegesen, R. Takchi, P. Hu, D. Santra, V. Strulev, E. Rubio-Azpeitia, C. Albrecht, A. Perrot, M. Cavo
发表在 Haematologica (2025-09-01)获取全文
文件 -
9
P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FRO... 由 E. K. Mai, U. Bertsch, R. Fenk, D. Tichy, B. Besemer, J. Dürig, R. Schroers, I. von Metzler, M. Hänel, C. Mann, A. M. Asemissen, B. Heilmeier, E. Nievergall, S. Huhn, K. Kriegsmann, N. Weinhold, S. Luntz, T. A. W. Holderrried, K. Trautmann-Grill, D. Gezer, M. Klaiber-Hakimi, M. Müller, C. Khandanpour, W. Knauf, C. Scheid, M. Munder, T. Geer, H. Riesenberg, J. Thomalla, M. Hoffmann, M. S. Raab, H. J. Salwender, K. C. Weisel, H. Goldschmidt
发表在 HemaSphere (2022-06-01)获取全文
文件 -
10
C062 | FIRST RESULTS FROM REALITAL: A EUROPEAN MULTICOUNTRY OBSERVATIONAL RETROSPECTIVE STUDY OF TALQUETAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OUTSIDE OF CLINIC... 由 M.C. Da Vià, K.M. Kortüm, R. Popat, K. Uttervall, V. Mykytiv, H. Magen, E. Antonioli, C. Liberatore, E. Zamagni, M. Hansson, M. Musso, J. Krawczyk, T. Shragai, K. Weisel, R. Teipel, D. Knut-Bojanowska, C. Toftmann Hansen, P. Hayden, M. Haenel, M-S. Raab, F. Pane, S. Leeth Farmer, M.E. Gatt, V. De Stefano, B. Kishore, S. Strifler, R. Takchi, P. Hu, D. Santra, V. Strulev, E. Rubio-Azpeitia, E. Aeby, K. Subrt, C. Albrecht, N. Martin Suñe, A. Perrot
发表在 Haematologica (2025-09-01)获取全文
文件 -
11
P11 | PERIPHERAL MEASURABLE RESIDUAL DISEASE ACTIVITY ASSESSMENT BY MALDI-TOF MASS SPECTROMETRY IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA IN THE PHASE 3 GMMG-HD7 TRIAL 由 J.X. Jin, V.R. Ginde, S. Huhn, Ph. Reichert, U. Bertsch, R. Fenk, B. Besemer, A. Boquoi, R. Schroers, I. Von Metzler, M. Hänel, Ch. Mann, L.B. Leypoldt, B. Heilmeier, C. Scheid, T. Peters-Regehr, I.W. Blau, C. Müller-Tidow, S. Luntz, T.A.W. Holderried, K. Trautmann-Grill, D. Gezer, M. Klaiber-Hakimi, M. Müller, E. Shumilov, W. Knauf, C.S. Michel, T. Geer, H. Riesenberg, Ch. Lutz, M.S. Raab, N. Weinhold, M. Hoffmann, A. Benner, P. Findeisen, K.C. Weisel, H.J. Salwender, H. Goldschmidt, E.K. Mai
发表在 Haematologica (2026-04-01)获取全文
文件 -
12
Who, When, and How: Watchful Waiting in the ERSPC Rotterdam 由 Jeroen J. Lodder, Esmée F.H. Mulder, Sebastiaan Remmers, Roderick C.N. van den Bergh, Chris H. Bangma, Monique J. Roobol, W.J. Kirkels, J.B.W. Rietbergen, I.W. van der Cruijsen, R. Raaijmakers, S.H. de Vries, S. Roemeling, C. Gosselaar, T. Wolters, R.C.N. van den Bergh, P.J. van Leeuwen, M. Bul, X. Zhu, L.P. Bokhorst, A.R. Alberts, F-J. Drost, J.F.M. Verbeek, D.F. Osses, H.B. Luiting, R. Hogenhout, R.C.A. Leenen, J.J. Lodder, M.J. van Harten, S.F. Westerhout, F. Denijs, E.F.H. Mulder, L.D.F. Venderbos, K. Beyer, H.A. van Vugt, G. Yurdakul, A. Boeken-Kruger, C. Wijburg, M. Forouzanfor, M. de Boer, R. Postma, A.N. Vis, Th van der Kwast, R. Hoedemaeker, A. van Leenders, R. van Schaik, P.J. van der Maas, H.J. De Koning, E.A. Heijnsdijk, S. Otto, G. Draisma, P. Beemsterboer, I. Korfage, R. Boer, M. Wildhagen, D. Nieboer, W. Merkelbach, W. Hoekstra, J. Blom, T. Lock, A. Noordzij, RAM Damhuis, A. Reedijk, R. Kranse, D.W. Roobol, W. Roobol, E. van den Berg, G-J. de Zwart, C.G.A.M. Franken-Raab, M. van Slooten-Midderig, A. Smit, V. van der Drift, E. de Bilde, M. den Rooijen, L. Mani, M. Visser-van Dongen, H. Versteeg-Leenheer, B. Zoutendijk, H. van Meurs, A.E. de Bruijn
发表在 European Urology Open Science (2026-05-01)获取全文
文件
